Search Results - "Ma, Yaojia"

S1576 Identification of CD4+ T Cells Expression Profiles Based on Transcriptome Analysis Between Primary Sclerosing Cholangitis and Ulcerative Colitis by Zhang, Jiaqi, Nakagawa, Ryo, Ouchi, Mayu, Ohta, Yuki, Ogawa, Keita, Qiang, Na, Kogure, Tadayoshi, Ao, Junjie, Ma, Yaojia, Kaneko, Tatsuya, Kan, Motoyasu, Goto, Chihiro, Kojima, Ryuta, Nakamoto, Shingo, Nakamura, Masato, Kato, Jun, Kato, Naoya

Get full text

Alteration of the tumor microenvironment by pharmacological inhibition of EZH2 in hepatocellular carcinoma by Qiang, Na, Ao, Junjie, Nakamura, Masato, Chiba, Tetsuhiro, Kusakabe, Yuko, Kaneko, Tatsuya, Kurosugi, Akane, Kogure, Tadayoshi, Ma, Yaojia, Zhang, Jiaqi, Ogawa, Keita, Kan, Motoyasu, Iwanaga, Terunao, Sakuma, Takafumi, Kanayama, Kengo, Kanzaki, Hiroaki, Kojima, Ryuta, Nakagawa, Ryo, Kondo, Takayuki, Nakamoto, Shingo, Muroyama, Ryosuke, Kato, Jun, Mimura, Naoya, Ma, Anqi, Jin, Jian, Kato, Naoya

“…•Pharmacological inhibition of EZH2 results in increasing MDSCs and attenuating CD8+ T cells in the tumor microenvironment of HCC.•Depletion of MDSCs by…”
Get full text

Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus by Ma, Yaojia, Nakamoto, Shingo, Ao, Junjie, Qiang, Na, Kogure, Tadayoshi, Ogawa, Keita, Nakagawa, Miyuki, Fujiwara, Kisako, Iwanaga, Terunao, Kojima, Ryuta, Kanzaki, Hiroaki, Koroki, Keisuke, Kobayashi, Kazufumi, Kanogawa, Naoya, Kiyono, Soichiro, Nakamura, Masato, Kondo, Takayuki, Nakagawa, Ryo, Ogasawara, Sadahisa, Muroyama, Ryosuke, Chiba, Tetsuhiro, Kato, Jun, Kato, Naoya

“…A functional cure of hepatitis B virus (HBV) infection or HB antigen loss is rarely achieved by nucleos(t)ide analogs which target viral polymerase. HBx…”
Get full text

Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors by Ogawa, Keita, Chiba, Tetsuhiro, Nakamura, Masato, Arai, Jun, Zhang, Jiaqi, Ma, Yaojia, Qiang, N A, Ao, Junjie, Yumita, Sae, Ishino, Takamasa, Kan, Motoyasu, Iwanaga, Terunao, Nakagawa, Miyuki, Fujiwara, Kisako, Sakuma, Takafumi, Kanzaki, Hiroaki, Koroki, Keisuke, Kusakabe, Yuko, Kobayashi, Kazufumi, Kanogawa, Naoya, Kiyono, Soichiro, Kondo, Takayuki, Nakagawa, Ryo, Ogasawara, Sadahisa, Muroyama, Ryosuke, Nakamoto, Shingo, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Jun, Matsumoto, Shoji, Arai, Takayoshi, Motohashi, Shinichiro, Kato, Naoya

“…MHC-class I-related chain A (MICA) functions as a ligand for natural killer group D, an activating receptor on natural killer (NK) cells, and its expression…”
Get more information

Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma by Ao, Junjie, Chiba, Tetsuhiro, Kanzaki, Hiroaki, Kanayama, Kengo, Shibata, Shuhei, Kurosugi, Akane, Iwanaga, Terunao, Kan, Motoyasu, Sakuma, Takafumi, Qiang, Na, Ma, Yaojia, Kojima, Ryuta, Kusakabe, Yuko, Nakamura, Masato, Kobayashi, Kazufumi, Kiyono, Soichiro, Kanogawa, Naoya, Saito, Tomoko, Nakagawa, Ryo, Kondo, Takayuki, Ogasawara, Sadahisa, Suzuki, Eiichiro, Nakamoto, Shingo, Muroyama, Ryosuke, Tawada, Akinobu, Kato, Jun, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Naoya

“…Hepatocellular carcinoma (HCC) is typically accompanied by abundant arterial blood flow. Although angiogenic growth factors such as Angiopoietin 2 (Ang2) play…”
Get full text

Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cells by Ao, Junjie, Chiba, Tetsuhiro, Shibata, Shuhei, Kurosugi, Akane, Qiang, Na, Ma, Yaojia, Kan, Motoyasu, Iwanaga, Terunao, Sakuma, Takafumi, Kanzaki, Hiroaki, Kanayama, Kengo, Kojima, Ryuta, Kusakabe, Yuko, Nakamura, Masato, Saito, Tomoko, Nakagawa, Ryo, Kondo, Takayuki, Ogasawara, Sadahisa, Suzuki, Eiichiro, Muroyama, Ryosuke, Kato, Jun, Mimura, Naoya, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Naoya

“…Lenvatinib is one of the first-line drugs for patients with advanced hepatocellular carcinoma (HCC) and widely used around the world. However, the mechanisms…”
Get full text

A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis by Sakuma, Takafumi, Nakamura, Masato, Chiba, Tetsuhiro, Iwanaga, Terunao, Kan, Motoyasu, Kojima, Ryuta, Ao, Junjie, Ma, Yaojia, Unozawa, Hidemi, Fujita, Naoto, Kanayama, Kengo, Kanzaki, Hiroaki, Koroki, Keisuke, Kobayashi, Kazufumi, Nakagawa, Ryo, Kanogawa, Naoya, Kiyono, Soichiro, Kondo, Takayuki, Saito, Tomoko, Ogasawara, Sadahisa, Nakamoto, Shingo, Muroyama, Ryosuke, Kato, Jun, Kishimoto, Takashi, Kato, Naoya

“…Non-alcoholic fatty liver disease (NAFLD) has become the leading cause of chronic liver disease worldwide. Patients with NAFLD often suffer steatohepatitis,…”
Get full text

Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cells by Iwanaga, Terunao, Chiba, Tetsuhiro, Nakamura, Masato, Kaneko, Tatsuya, Ao, Junjie, Qiang, Na, Ma, Yaojia, Zhang, Jiaqi, Kogure, Tadayoshi, Yumita, Sae, Ishino, Takamasa, Ogawa, Keita, Kan, Motoyasu, Nakagawa, Miyuki, Fujiwara, Kisako, Fujita, Naoto, Sakuma, Takafumi, Kanzaki, Hiroaki, Koroki, Keisuke, Kusakabe, Yuko, Inoue, Masanori, Kobayashi, Kazufumi, Kanogawa, Naoya, Kiyono, Soichiro, Kondo, Takayuki, Nakagawa, Ryo, Ogasawara, Sadahisa, Nakamoto, Shingo, Muroyama, Ryosuke, Kato, Jun, Kanda, Tatsuo, Maruyama, Hitoshi, Mimura, Naoya, Honda, Takuya, Murayama, Toshihiko, Nakamura, Hiroyuki, Kato, Naoya

“…Transforming growth factor (TGF)-β/Smad pathway is implicated in the pathogenesis of liver fibrosis, a condition characterized by excessive deposition of…”
Get full text

Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinoma by Kojima, Ryuta, Nakamoto, Shingo, Kogure, Tadayoshi, Ma, Yaojia, Ogawa, Keita, Iwanaga, Terunao, Qiang, Na, Ao, Junjie, Nakagawa, Ryo, Muroyama, Ryosuke, Nakamura, Masato, Chiba, Tetsuhiro, Kato, Jun, Kato, Naoya

“…Hepatitis B virus (HBV) is a major cause of hepatocellular carcinoma (HCC). HBV DNA can get integrated into the hepatocyte genome to promote carcinogenesis…”
Get full text

Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience by Ogawa, Keita, Kanzaki, Hiroaki, Chiba, Tetsuhiro, Ao, Junjie, Qiang, Na, Ma, Yaojia, Zhang, Jiaqi, Yumita, Sae, Ishino, Takamasa, Unozawa, Hidemi, Kan, Motoyasu, Iwanaga, Terunao, Nakagawa, Miyuki, Fujiwara, Kisako, Fujita, Naoto, Sakuma, Takafumi, Koroki, Keisuke, Kusakabe, Yuko, Kobayashi, Kazufumi, Kanogawa, Naoya, Kiyono, Soichiro, Nakamura, Masato, Kondo, Takayuki, Saito, Tomoko, Nakagawa, Ryo, Ogasawara, Sadahisa, Suzuki, Eiichiro, Nakamoto, Shingo, Muroyama, Ryosuke, Kanda, Tatsuo, Maruyama, Hitoshi, Mimura, Naoya, Kato, Jun, Motohashi, Shinichiro, Kato, Naoya

“…Atezolizumab plus bevacizumab (ATZ/BV) treatment is a combined immunotherapy consisting of immune checkpoint inhibitor (ICI) and anti-vascular endothelial…”
Get full text

A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis by Sakuma, Takafumi, Nakamura, Masato, Chiba, Tetsuhiro, Iwanaga, Terunao, Kan, Motoyasu, Kojima, Ryuta, Ao, Junjie, Ma, Yaojia, Unozawa, Hidemi, Fujita, Naoto, Kanayama, Kengo, Kanzaki, Hiroaki, Koroki, Keisuke, Kobayashi, Kazufumi, Nakagawa, Ryo, Kanogawa, Naoya, Kiyono, Soichiro, Kondo, Takayuki, Saito, Tomoko, Ogasawara, Sadahisa, Nakamoto, Shingo, Muroyama, Ryosuke, Kato, Jun, Kishimoto, Takashi, Kato, Naoya

“…Non-alcoholic fatty liver disease (NAFLD) has become the leading cause of chronic liver disease worldwide. Patients with NAFLD often suffer steatohepatitis,…”
Get full text

EP1182: PATHOGENESIS OF PRIMARY SCLEROSING CHOLANGITIS BY BILE PROTEOME ANALYSIS USING HIGH-PRECISION MASS SPECTROMETRY by Kan, Motoyasu, Chiba, Tetsuhiro, Konno, Ryo, Kawashima, Yusuke, Ogawa, Keita, Iwanaga, Terunao, Sakuma, Takafumi, Ao, Junjie, Qiang, Na, Ma, Yaojia, Zhang, Jiaqi, Miura, Yoshifumi, Kojima, Ryuta, Nagashima, Hiroki, Takahashi, Koji, Kusakabe, Yuko, Nakamura, Masato, Ohyama, Hiroshi, Sugiyama, Haretoshi, Ohno, Izumi, Mikata, Rintaro, Ohara, Osamu, Kato, Naoya

Get full text